Avantor Inc
AVTR11.095USD
-0.105-0.94%
Close 12/17, 16:00（ET）Quotes delayed by 15 min
7.57BMarket Cap
LossP/E TTM
More Details of Avantor Inc Company
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Avantor Inc Info
Ticker SymbolAVTR
Company nameAvantor Inc
IPO dateMay 17, 2019
CEOLigner (Emmanuel)
Number of employees13500
Security typeOrdinary Share
Fiscal year-endMay 17
AddressRadnor Corporate Center, Building One
CityRADNOR
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code19087
Phone16103861700
Websitehttps://www.avantorsciences.com/
Ticker SymbolAVTR
IPO dateMay 17, 2019
CEOLigner (Emmanuel)
Company Executives of Avantor Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Jonathan Peacock
Mr. Jonathan Peacock
Independent Chairman of the Board
Independent Chairman of the Board
346.55K
+5.19%
Mr. Emmanuel Ligner
Mr. Emmanuel Ligner
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.42K
+44.66%
Mr. Christophe Couturier
Mr. Christophe Couturier
Executive Vice President, AMEA
Executive Vice President, AMEA
205.79K
+46.39%
Mr. Benoit Gourdier
Mr. Benoit Gourdier
Executive Vice President - Bioscience Production
Executive Vice President - Bioscience Production
200.69K
-0.63%
Ms. Brittany Hankamer
Ms. Brittany Hankamer
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
171.56K
-0.11%
Mr. Juan Andres
Mr. Juan Andres
Independent Director
Independent Director
57.00K
+42.85%
Dr. Michael E. Severino, M.D.
Dr. Michael E. Severino, M.D.
Independent Director
Independent Director
52.07K
+48.89%
Ms. Lan Kang
Ms. Lan Kang
Independent Director
Independent Director
43.84K
+63.95%
Ms. Kitty Sahin
Ms. Kitty Sahin
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
42.27K
-8.51%
Mr. Gregory L. (Greg) Summe
Mr. Gregory L. (Greg) Summe
Independent Chairman of the Board
Independent Chairman of the Board
39.83K
+75.24%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Jonathan Peacock
Mr. Jonathan Peacock
Independent Chairman of the Board
Independent Chairman of the Board
346.55K
+5.19%
Mr. Emmanuel Ligner
Mr. Emmanuel Ligner
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.42K
+44.66%
Mr. Christophe Couturier
Mr. Christophe Couturier
Executive Vice President, AMEA
Executive Vice President, AMEA
205.79K
+46.39%
Mr. Benoit Gourdier
Mr. Benoit Gourdier
Executive Vice President - Bioscience Production
Executive Vice President - Bioscience Production
200.69K
-0.63%
Ms. Brittany Hankamer
Ms. Brittany Hankamer
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
171.56K
-0.11%
Mr. Juan Andres
Mr. Juan Andres
Independent Director
Independent Director
57.00K
+42.85%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Proprietary materials & consumables
893.80M
53.09%
Third party materials & consumables
789.60M
46.91%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Proprietary materials & consumables
893.80M
53.09%
Third party materials & consumables
789.60M
46.91%
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Dodge & Cox
17.27%
The Vanguard Group, Inc.
9.65%
BlackRock Institutional Trust Company, N.A.
7.89%
Barrow Hanley Global Investors
5.07%
T. Rowe Price Investment Management, Inc.
4.83%
Other
55.29%
Shareholders
Shareholders
Proportion
Dodge & Cox
17.27%
The Vanguard Group, Inc.
9.65%
BlackRock Institutional Trust Company, N.A.
7.89%
Barrow Hanley Global Investors
5.07%
T. Rowe Price Investment Management, Inc.
4.83%
Other
55.29%
Shareholder Types
Shareholders
Proportion
Investment Advisor
47.62%
Investment Advisor/Hedge Fund
42.40%
Hedge Fund
5.09%
Private Equity
2.13%
Research Firm
1.73%
Pension Fund
1.48%
Individual Investor
1.42%
Sovereign Wealth Fund
1.22%
Family Office
1.16%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
1132
697.26M
116.93%
+48.80K
2025Q3
1170
697.28M
119.49%
-22.58M
2025Q2
1155
719.65M
112.74%
+18.62M
2025Q1
1132
700.71M
113.08%
-69.85M
2024Q4
1131
694.99M
113.80%
-158.00
2024Q3
1115
693.95M
108.61%
+31.43M
2024Q2
1117
658.06M
105.51%
+8.42M
2024Q1
1107
649.09M
108.27%
-86.24M
2023Q4
1123
652.68M
103.73%
+15.33M
2023Q3
1111
639.87M
101.93%
+18.25M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Dodge & Cox
117.43M
17.23%
+17.17M
+17.13%
Jun 30, 2025
The Vanguard Group, Inc.
64.52M
9.46%
-112.01K
-0.17%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
55.80M
8.19%
-197.95K
-0.35%
Jun 30, 2025
Barrow Hanley Global Investors
31.19M
4.58%
+933.27K
+3.08%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
56.50M
8.29%
+14.53M
+34.62%
Jun 30, 2025
State Street Investment Management (US)
23.48M
3.44%
-113.16K
-0.48%
Jun 30, 2025
Clarkston Capital Partners, LLC
13.98M
2.05%
+4.39M
+45.77%
Jun 30, 2025
New Mountain Capital, LLC
14.00M
2.05%
--
--
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
First Trust Health Care Alphadex Fund
2.06%
John Hancock Fundamental All Cap Core ETF
1.24%
Invesco S&P MidCap Quality ETF
1.03%
First Trust Mid Cap Value AlphaDEX Fund
0.69%
Vanguard S&P Mid-Cap 400 Value Index Fund
0.55%
State Street SPDR S&P 400 Mid Cap Value ETF
0.53%
FPA Global Equity ETF
0.53%
Pacer Lunt MidCap Multi-Factor Alternator ETF
0.47%
First Trust Mid Cap Core Alphadex Fund
0.35%
NYLI Candriam US Mid Cap Equity ETF
0.35%
View more
First Trust Health Care Alphadex Fund
Proportion2.06%
John Hancock Fundamental All Cap Core ETF
Proportion1.24%
Invesco S&P MidCap Quality ETF
Proportion1.03%
First Trust Mid Cap Value AlphaDEX Fund
Proportion0.69%
Vanguard S&P Mid-Cap 400 Value Index Fund
Proportion0.55%
State Street SPDR S&P 400 Mid Cap Value ETF
Proportion0.53%
FPA Global Equity ETF
Proportion0.53%
Pacer Lunt MidCap Multi-Factor Alternator ETF
Proportion0.47%
First Trust Mid Cap Core Alphadex Fund
Proportion0.35%
NYLI Candriam US Mid Cap Equity ETF
Proportion0.35%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Avantor Inc?
The top five shareholders of Avantor Inc are:
Dodge & Cox holds 117.43M shares, accounting for 17.23% of the total shares.
The Vanguard Group, Inc. holds 64.52M shares, accounting for 9.46% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 55.80M shares, accounting for 8.19% of the total shares.
Barrow Hanley Global Investors holds 31.19M shares, accounting for 4.58% of the total shares.
T. Rowe Price Investment Management, Inc. holds 56.50M shares, accounting for 8.29% of the total shares.
Dodge & Cox holds 117.43M shares, accounting for 17.23% of the total shares.
The Vanguard Group, Inc. holds 64.52M shares, accounting for 9.46% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 55.80M shares, accounting for 8.19% of the total shares.
Barrow Hanley Global Investors holds 31.19M shares, accounting for 4.58% of the total shares.
T. Rowe Price Investment Management, Inc. holds 56.50M shares, accounting for 8.29% of the total shares.
What are the top three shareholder types of Avantor Inc?
The top three shareholder types of Avantor Inc are:
Dodge & Cox
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Dodge & Cox
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
How many institutions hold shares of Avantor Inc (AVTR)?
As of 2025Q4, 1132 institutions hold shares of Avantor Inc, with a combined market value of approximately 697.26M, accounting for 116.93% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -2.55%.
What is the biggest source of revenue for Avantor Inc?
In FY2025Q2, the Proprietary materials & consumables business generated the highest revenue for Avantor Inc, amounting to 893.80M and accounting for 53.09% of total revenue.
